State Street Corporation 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-18 10:59 am Purchase | 2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX | STATE STREET CORP STT | 12,870,272 4.700% | 718,626 (+5.91%) | Filing |
| 2024-01-24 10:13 am Purchase | 2023-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX | STATE STREET CORP STT | 12,151,646 5.830% | 12,151,646 (New Position) | Filing |